FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Zydus Pharmaceuticals Divalproex Sodium Delayed Release Tablets Recall

Divalproex Sodium Delayed Release Tablets, USP, 500 mg, a) 100 count (NDC 68382-033-01…

Zydus Pharmaceuticals USA Inc · Pennington, NJ

Risk level
Class II
Reported by FDA
Apr 5, 2017
Recall ID
D-0617-2017
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals recalled Divalproex Sodium Delayed Release Tablets starting Mar 15, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0617-2017 on Apr 5, 2017. Reason: Failed Dissolution Specifications; 9 month long term stability. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications; 9 month long term stability

Product description

Divalproex Sodium Delayed Release Tablets, USP, 500 mg, a) 100 count (NDC 68382-033-01) and b) 500 count (NDC 68382-033-05) bottles, Rx only, manufactured by Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals, Pennington, NJ

Lot numbers, UPCs & expiration codes

a) MR8221, MR8222 exp 7/31/2017; MR10260, exp 9/30/2017; MR10926, exp 10/31/2017; b) MR6187, exp 5/31/2017; MR7302, exp 6/30/2017; MR7768, MR7769, exp 7/31/2017; MR8247, exp 7/31/2017; MR8887, MR8892, MR8893 exp 8/31/2017; MR9014, MR10414 exp 9/30/2017; MR10928, exp 10/31/2017; MR11183, MR11185, MR11186, exp 11/30/2017

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0617-2017
Classification
Class II
Status
Terminated
Recall initiated
Mar 15, 2017
FDA report date
Apr 5, 2017
Quantity
32628 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals USA Inc

Original FDA data

Every field from FDA enforcement report D-0617-2017, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Terminated
Country
United States
Event ID
76737
Address
73 Route 31 N
Code information
a) MR8221, MR8222 exp 7/31/2017; MR10260, exp 9/30/2017; MR10926, exp 10/31/2017; b) MR6187, exp 5/31/2017; MR7302, exp 6/30/2017; MR7768, MR7769, exp 7/31/2017; MR8247, exp 7/31/2017; MR8887, MR8892, MR8893 exp 8/31/2017; MR9014, MR10414 exp 9/30/2017; MR10928, exp 10/31/2017; MR11183, MR11185, MR11186, exp 11/30/2017
Postal code
08534-3601
Report date
Apr 5, 2017
Product type
Drugs
Recall number
D-0617-2017
Classification
Class II
Recalling firm
Zydus Pharmaceuticals USA Inc
Product quantity
32628 bottles
Termination date
Sep 10, 2020
Reason for recall
Failed Dissolution Specifications; 9 month long term stability
Voluntary / mandated
Voluntary: Firm initiated
Product description
Divalproex Sodium Delayed Release Tablets, USP, 500 mg, a) 100 count (NDC 68382-033-01) and b) 500 count (NDC 68382-033-05) bottles, Rx only, manufactured by Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals, Pennington, NJ
Distribution pattern
Nationwide
Recall initiation date
Mar 15, 2017
Initial firm notification
Letter
Center classification date
Mar 27, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0617-2017, published Apr 5, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls